What are the causes and treatment options for exercise‑induced hypertension?

Exercise-Induced Hypertension: Causes and Treatment

Definition and Diagnostic Criteria

Exercise-induced hypertension (EIH) is defined as systolic blood pressure >210 mmHg in males or >190 mmHg in females during exercise 1. However, emerging evidence suggests that the mean pulmonary artery pressure (mPAP) over cardiac output slope exceeding 3 mmHg/L/min is a more reliable diagnostic indicator than absolute pressure cut-offs 2.

Causes and Pathophysiology

The mechanisms underlying EIH are not fully understood but involve several key factors 1, 3:

• Impaired arterial reactivity: Reduced flow-mediated dilation of arteries, particularly in the brachial artery, correlates inversely with peak exercise systolic pressure 4
• Enhanced sympathetic nervous activity: Elevated plasma norepinephrine during exercise contributes to excessive BP elevation 5
• Endothelial dysfunction: Prolonged excessive exercise reduces endothelial function and increases arterial stiffness, leading to increased afterload 3
• Ventricular hypertrophy: Creates an imbalance between oxygen demand and supply, independent of coronary artery disease 3
• Angiotensin II activity: Associated with EIH development, particularly in middle-aged runners 3

Clinical Significance

EIH is prevalent among athletes and healthy individuals without cardiovascular risk factors 1. An exaggerated BP response to exercise is a significant risk factor for future hypertension and cardiovascular disease 5, 6. It increases the morbidity rate of resting hypertension and is associated with critical arrhythmias including atrial fibrillation and ventricular arrhythmias 3.

Treatment Approach

Non-Pharmacological Management

For individuals with EIH, prescribe 30-60 minutes of moderate-intensity dynamic exercise (walking, jogging, cycling, swimming) 4-7 days per week 7. This recommendation may seem counterintuitive, but regular aerobic exercise at moderate intensity (40-60% of heart rate reserve) actually attenuates BP elevations during physical exertion 5, 8.

Key evidence supporting this approach:

• Regular aerobic exercise reduces BP during submaximal workloads and daytime activities by decreasing enhanced sympathetic nervous tone 5
• Exercise training lowers 24-hour and daytime ambulatory BP, though nighttime BP remains unchanged 5
• The BP-lowering effects are most pronounced in those with highest baseline BP, with reductions of approximately 5-7 mmHg 8

Critical caveat: Higher intensities of exercise are NOT more effective for BP reduction 7. For middle-aged long-distance runners with EIH, guidelines restricting exercise intensity and frequency are essential to prevent excessive participation 3.

Resistance Training Considerations

For individuals with systolic BP 140-159 mmHg or diastolic BP 90-99 mmHg, resistance or weight training exercise does not adversely influence BP 7. This includes free-weight lifting, fixed-weight lifting, or handgrip exercise.

Lifestyle Modifications (Essential Adjuncts)

1. Weight management: Maintain BMI 18.5-24.9 kg/m² and waist circumference <102 cm (men) or <88 cm (women) 7

2. Dietary modifications:

   • Follow DASH diet emphasizing fruits, vegetables, low-fat dairy, whole grains, and plant proteins 7
   • Reduce sodium intake toward 2000 mg (87 mmol) per day 9
   • Increase potassium intake by 0.5-1.0 g/day to achieve Na+/K+ ratio of 1.5-2.0 10

3. Alcohol restriction: Abstain or limit to ≤2 drinks per day 7

4. Smoking cessation: Mandatory for all patients 7

Pharmacological Management

When lifestyle modifications are insufficient, angiotensin II receptor blockers (ARBs) show promising effects for EIH, particularly in middle-aged runners 3.

For hypertensive athletes requiring medication, the drugs of choice are:

1. First-line: ACE inhibitors or ARBs 11, 8
2. Second-line: Calcium channel blockers 11, 8
3. Third-line (if needed): Low-dose thiazide diuretics 12

Avoid in athletes:

• Beta-blockers (impair exercise performance and are on doping lists) 11
• Non-dihydropyridine calcium channel blockers (verapamil, diltiazem) in heart failure 12
• Alpha-blockers as first-line agents 12

Specific Evidence for ARBs in EIH

Telmisartan demonstrates differential effects based on timing: Morning dosing more effectively lowers exercise-induced BP spikes, while bedtime dosing improves nocturnal BP control 13. For EIH specifically, morning administration of telmisartan 40 mg is preferable to target exercise-related BP elevations.

Monitoring and Follow-up

If EIH is detected (exercise systolic BP ≥170 mmHg), assume uncontrolled hypertension and initiate 6:

1. Correspondence with primary care physician for follow-up testing
2. Home BP monitoring to ascertain BP status
3. With confirmed elevated BP, implement ongoing exercise and lifestyle intervention

Ambulatory BP monitoring should be performed using duplicate measures, morning and evening, for 7 days (excluding first-day values) 9, 14.

Target Blood Pressure

Target BP should be <130/80 mmHg, with consideration for lowering to <120/80 mmHg in selected patients 12. However, caution is advised when lowering diastolic BP below 60 mmHg in patients with diabetes or those over 60 years with coronary artery disease 12.